 Von Samedi
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathologists | 1 | 2021 | 16 | 0.710 |
Why?
| | Minority Groups | 1 | 2021 | 249 | 0.610 |
Why?
| | Head and Neck Neoplasms | 4 | 2024 | 542 | 0.580 |
Why?
| | Abdominal Pain | 2 | 2015 | 143 | 0.530 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 127 | 0.490 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2017 | 197 | 0.470 |
Why?
| | Pancreatitis | 1 | 2015 | 129 | 0.440 |
Why?
| | Endovascular Procedures | 1 | 2017 | 301 | 0.410 |
Why?
| | Celiac Disease | 1 | 2015 | 286 | 0.380 |
Why?
| | Ascites | 2 | 2014 | 44 | 0.370 |
Why?
| | Mesothelioma | 1 | 2010 | 38 | 0.340 |
Why?
| | Peritoneal Neoplasms | 1 | 2010 | 86 | 0.330 |
Why?
| | Thy-1 Antigens | 2 | 2020 | 11 | 0.320 |
Why?
| | Biopsy | 4 | 2020 | 1084 | 0.310 |
Why?
| | Down Syndrome | 1 | 2015 | 477 | 0.300 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 195 | 0.270 |
Why?
| | Crohn Disease | 2 | 2020 | 215 | 0.250 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.220 |
Why?
| | Mouth Neoplasms | 1 | 2023 | 84 | 0.200 |
Why?
| | Ascitic Fluid | 2 | 2014 | 14 | 0.200 |
Why?
| | Larynx | 1 | 2023 | 57 | 0.200 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2023 | 64 | 0.200 |
Why?
| | Prisoners | 1 | 2025 | 141 | 0.200 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 42 | 0.200 |
Why?
| | Health Status Disparities | 1 | 2025 | 251 | 0.190 |
Why?
| | Th1 Cells | 2 | 2020 | 137 | 0.180 |
Why?
| | Tonsillar Neoplasms | 1 | 2020 | 8 | 0.180 |
Why?
| | Neoplasms, Unknown Primary | 1 | 2020 | 13 | 0.170 |
Why?
| | Palatine Tonsil | 1 | 2020 | 45 | 0.170 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2020 | 36 | 0.170 |
Why?
| | Recurrence | 2 | 2015 | 1005 | 0.160 |
Why?
| | Abscess | 1 | 2020 | 73 | 0.160 |
Why?
| | Radiosurgery | 1 | 2022 | 320 | 0.160 |
Why?
| | Matrix Metalloproteinases | 1 | 2020 | 90 | 0.160 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 296 | 0.160 |
Why?
| | Tonsillectomy | 1 | 2020 | 82 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 574 | 0.150 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2023 | 625 | 0.150 |
Why?
| | Angiomyolipoma | 1 | 2018 | 17 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 352 | 0.150 |
Why?
| | Intestinal Neoplasms | 1 | 2018 | 28 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 105 | 0.140 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 48 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2017 | 39 | 0.140 |
Why?
| | Aortography | 1 | 2017 | 51 | 0.140 |
Why?
| | Stomach Neoplasms | 1 | 2018 | 97 | 0.140 |
Why?
| | Colitis, Ulcerative | 1 | 2018 | 118 | 0.130 |
Why?
| | Neuroendocrine Tumors | 1 | 2018 | 99 | 0.130 |
Why?
| | Isoflavones | 2 | 2007 | 25 | 0.130 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 123 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1429 | 0.130 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 114 | 0.130 |
Why?
| | Cell Membrane | 1 | 2020 | 732 | 0.130 |
Why?
| | Hemochromatosis | 1 | 2015 | 8 | 0.120 |
Why?
| | Humans | 21 | 2025 | 129144 | 0.120 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2015 | 72 | 0.120 |
Why?
| | Duodenoscopy | 1 | 2015 | 7 | 0.120 |
Why?
| | Acute Disease | 2 | 2015 | 978 | 0.120 |
Why?
| | Ferritins | 1 | 2015 | 58 | 0.120 |
Why?
| | Diet, Gluten-Free | 1 | 2015 | 42 | 0.120 |
Why?
| | Fibroblasts | 1 | 2020 | 947 | 0.110 |
Why?
| | Genistein | 2 | 2006 | 13 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2018 | 347 | 0.110 |
Why?
| | Prostatic Neoplasms | 3 | 2007 | 996 | 0.110 |
Why?
| | Stents | 1 | 2017 | 502 | 0.100 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 381 | 0.100 |
Why?
| | Prednisone | 1 | 2014 | 233 | 0.100 |
Why?
| | Antibodies, Neutralizing | 1 | 2015 | 265 | 0.100 |
Why?
| | Colonic Neoplasms | 1 | 2015 | 241 | 0.100 |
Why?
| | Gastritis | 1 | 2014 | 96 | 0.100 |
Why?
| | Enteritis | 1 | 2014 | 93 | 0.100 |
Why?
| | Hepatitis C | 1 | 2015 | 238 | 0.100 |
Why?
| | Cholestasis | 1 | 2015 | 232 | 0.100 |
Why?
| | Extracellular Matrix | 1 | 2016 | 502 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 441 | 0.100 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 426 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2017 | 10192 | 0.090 |
Why?
| | Eosinophilia | 1 | 2014 | 204 | 0.090 |
Why?
| | Adult | 7 | 2020 | 35469 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 563 | 0.090 |
Why?
| | Macrophages | 2 | 2015 | 1481 | 0.090 |
Why?
| | Peritoneum | 1 | 2010 | 41 | 0.090 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1678 | 0.090 |
Why?
| | Autopsy | 1 | 2010 | 90 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2007 | 1336 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 879 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1943 | 0.080 |
Why?
| | Fatal Outcome | 1 | 2010 | 299 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2014 | 578 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 748 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 607 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1932 | 0.070 |
Why?
| | Mice | 6 | 2024 | 16905 | 0.070 |
Why?
| | Soybean Proteins | 1 | 2006 | 14 | 0.060 |
Why?
| | Phytoestrogens | 1 | 2006 | 17 | 0.060 |
Why?
| | Male | 9 | 2018 | 63456 | 0.060 |
Why?
| | Skin | 1 | 2010 | 726 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 177 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1056 | 0.060 |
Why?
| | Interleukin-8 | 1 | 2006 | 262 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2735 | 0.060 |
Why?
| | Female | 8 | 2023 | 68494 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 26 | 0.050 |
Why?
| | Phosphatidylinositols | 1 | 2023 | 57 | 0.050 |
Why?
| | Carcinogens | 1 | 2023 | 110 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 226 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 158 | 0.050 |
Why?
| | Gene Expression | 1 | 2007 | 1463 | 0.050 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 77 | 0.050 |
Why?
| | Animals | 6 | 2024 | 35286 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2023 | 213 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 164 | 0.050 |
Why?
| | Trachea | 1 | 2023 | 220 | 0.050 |
Why?
| | Aged | 3 | 2023 | 21997 | 0.040 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 203 | 0.040 |
Why?
| | Tonsillitis | 1 | 2020 | 6 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 379 | 0.040 |
Why?
| | Unnecessary Procedures | 1 | 2020 | 48 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 627 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1198 | 0.040 |
Why?
| | Th17 Cells | 1 | 2020 | 83 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2007 | 755 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 2012 | 0.040 |
Why?
| | Immunotherapy | 1 | 2022 | 590 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 854 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 2025 | 899 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 140 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2018 | 305 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2018 | 121 | 0.030 |
Why?
| | Atrial Remodeling | 1 | 2016 | 9 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2699 | 0.030 |
Why?
| | Immunoblotting | 1 | 2016 | 305 | 0.030 |
Why?
| | Actins | 1 | 2018 | 411 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 375 | 0.030 |
Why?
| | Pancreas | 1 | 2018 | 303 | 0.030 |
Why?
| | Phlebotomy | 1 | 2015 | 18 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 96 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2015 | 188 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 5438 | 0.030 |
Why?
| | Liver Failure | 1 | 2015 | 91 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2016 | 423 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1109 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2635 | 0.030 |
Why?
| | Ileum | 1 | 2014 | 115 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2016 | 713 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 589 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 180 | 0.030 |
Why?
| | Tumor Cells, Cultured | 2 | 2006 | 943 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 31050 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1384 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 1054 | 0.020 |
Why?
| | Chronic Pain | 1 | 2014 | 252 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 449 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2536 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2511 | 0.020 |
Why?
| | United States | 1 | 2025 | 13825 | 0.020 |
Why?
| | Cyclin B | 1 | 2007 | 15 | 0.020 |
Why?
| | Forkhead Box Protein O3 | 1 | 2007 | 15 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 74 | 0.020 |
Why?
| | Biological Availability | 1 | 2007 | 147 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3963 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 160 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 117 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 160 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 183 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 405 | 0.010 |
Why?
| | Down-Regulation | 1 | 2007 | 636 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 1896 | 0.010 |
Why?
| | Cell Cycle | 1 | 2007 | 588 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 838 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 2129 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2008 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 2002 | 192 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 270 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2002 | 256 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 12385 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1416 | 0.010 |
Why?
| | Mice, Nude | 1 | 2002 | 682 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 796 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1683 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3186 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2368 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20297 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1396 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2002 | 584 | 0.010 |
Why?
|
|
Samedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|